Am J Perinatol 2024; 41(S 01): e664-e670
DOI: 10.1055/a-1925-8643
Original Article

Toward Optimal High Continuous Positive Airway Pressure as Postextubation Support in Preterm Neonates: A Retrospective Cohort Study

Lana Khalid
1   Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
,
Said al-Balushi
1   Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
,
Nandita Manoj
2   Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
,
Sufyan Rather
2   Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
,
Heather Johnson
1   Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
,
Laura Strauss
3   Department of Respiratory Therapy, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada
,
4   Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab, India
,
Amit Mukerji
1   Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
› Institutsangaben
Funding None.

Abstract

Objective This study aimed to evaluate whether the initial pressure level on high continuous positive airway pressure (CPAP; ≥9 cm H2O), in relation to preextubation mean airway pressure (Paw), influences short-term clinical outcomes in preterm neonates.

Study Design In this retrospective cohort study, preterm neonates <29 weeks' gestational age (GA) extubated from mean Paw ≥9 cm H2O and to high CPAP (≥9 cm H2O) were classified into “higher level CPAP” (2–3 cm H2O higher than preextubation Paw) and “equivalent CPAP” (−1 to +1 cm H2O in relation to preextubation Paw). Only the first eligible extubation per infant was analyzed. The primary outcome was failure within ≤7 days of extubation, defined as any one or more of (1) need for reintubation, (2) escalation to an alternate noninvasive respiratory support mode, or (3) use of CPAP >preextubation Paw + 3 cm H2O. Secondary outcomes included individual components of the primary outcome, along with other clinical and safety outcomes.

Results Over a 10-year period (Jan 2011–Dec 2020), 175 infants were extubated from mean Paw >9 cm H2O to high CPAP pressures. Twenty-seven patients (median GA = 24.7, [interquartile range (IQR)]: (24.0–26.4) weeks and chronological age = 31, IQR: [21–40] days) were classified into the “higher level CPAP” group while 148 infants (median GA = 25.4, IQR: [24.6–26.6] weeks and chronological age = 26, IQR: [10–39] days) comprised the “equivalent CPAP” group. There was no difference in the primary outcome (44 vs. 51%; p = 0.51), including postadjustment for confounders (adjusted OR [aOR] = 0.47 [95% confidence interval (CI): 0.17–1.29; p = 0.14]). However, reintubation risk within 7 days was lower with higher level CPAP (7 vs. 37%; p < 0.01), including postadjustment (aOR = 0.07; 95% CI: 0.02–0.35; p < 0.01).

Conclusion In this cohort, use of initial distending CPAP pressures 2 to 3 cm H2O higher than preextubation Paw did not alter the primary outcome of failure but did lower the risk of reintubation. The latter is an interesting hypothesis-generating finding that requires further confirmation.

Key Points

  • Use of high CPAP pressures (≥9 cm H2O) is gradually increasing in the care of preterm neonates.

  • This study compares higher level versus equivalent CPAP in relation to preextubation Paw.

  • The findings demonstrate no difference in failure as defined with use of higher level CPAP pressures.

Ethics Approval

The study protocol was approved by the Hamilton Integrated Research Ethics Board (REB no.: 5461). Consent was waived by the ethics board in light of the retrospective nature of the study design.


Authors' Contributions

L.K., S.A., N.M., S.R., and H.J. performed the primary data collection for all patients. L.S. and S.D. provided methodological input in study design and analysis. A.M. devised the study concept, performed statistical analyses and revised the manuscript into its final form. All authors approved the final version of the manuscript.


Supplementary Material



Publikationsverlauf

Eingereicht: 21. Juni 2022

Angenommen: 17. August 2022

Accepted Manuscript online:
17. August 2022

Artikel online veröffentlicht:
01. Oktober 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF. Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 2003; 289 (09) 1124-1129
  • 2 Keszler M, Sant'Anna G. Mechanical Ventilation and Bronchopulmonary Dysplasia. Clin Perinatol 2015; 42 (04) 781-796
  • 3 Fischer HS, Bührer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics 2013; 132 (05) e1351-e1360
  • 4 Jensen EA, DeMauro SB, Kornhauser M, Aghai ZH, Greenspan JS, Dysart KC. Effects of multiple ventilation courses and duration of mechanical ventilation on respiratory outcomes in extremely low-birth-weight infants. JAMA Pediatr 2015; 169 (11) 1011-1017
  • 5 Mukerji A, Shah PS, Shivananda S. et al; Canadian Neonatal Network Investigators. Survey of noninvasive respiratory support practices in Canadian neonatal intensive care units. Acta Paediatr 2017; 106 (03) 387-393
  • 6 Bamat N, Fierro J, Mukerji A, Wright CJ, Millar D, Kirpalani H. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2021; 11 (11) CD012778
  • 7 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806
  • 8 Ahmad HA, Deekonda V, Patel W, Thabane L, Shah PS, Mukerji A. Comparison of high CPAP versus NIPPV in preterm neonates: a retrospective cohort study. Am J Perinatol 2021
  • 9 Li G, Taljaard M, Van den Heuvel ER. et al. An introduction to multiplicity issues in clinical trials: the what, why, when and how. Int J Epidemiol 2017; 46 (02) 746-755
  • 10 Gupta D, Greenberg RG, Natarajan G. et al. Respiratory setback associated with extubation failure in extremely preterm infants. Pediatr Pulmonol 2021; 56 (07) 2081-2086
  • 11 Chawla S, Natarajan G, Shankaran S. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Markers of successful extubation in extremely preterm infants, and morbidity after failed extubation. J Pediatr 2017; 189: 113-119.e2
  • 12 Mukerji A, Abdul Wahab MG, Razak A. et al. High CPAP vs. NIPPV in preterm neonates - a physiological cross-over study. J Perinatol 2021; 41 (07) 1690-1696
  • 13 Lemyre B, Davis PG, De Paoli AG, Kirpalani H. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev 2017; 2: CD003212
  • 14 Ferguson KN, Roberts CT, Manley BJ, Davis PG. Interventions to improve rates of successful extubation in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2017; 171 (02) 165-174
  • 15 Kidman AM, Manley BJ, Boland RA. et al. Protocol for a randomised controlled trial comparing two CPAP levels to prevent extubation failure in extremely preterm infants. BMJ Open 2021; 11 (06) e045897